v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2024   $ 15 $ 114,519 $ (102,440) $ 12,094
Balance at beginning of period (in shares) at Dec. 31, 2024 47 1,493,639      
Increase (Decrease) in Stockholders' Equity          
Net loss       (884) (884)
Issuance of common stock for Board fees and consulting services     65   65
Issuance of common stock for Board fees and consulting services (in shares)   10,673      
Stock-based compensation     423   423
Balance at end of period at Mar. 31, 2025   $ 15 115,007 (103,324) 11,698
Balance at end of period (in shares) at Mar. 31, 2025 47 1,504,312      
Balance at beginning of period at Dec. 31, 2025   $ 18 117,346 (102,803) 14,561
Balance at beginning of period (in shares) at Dec. 31, 2025 47 1,780,899      
Increase (Decrease) in Stockholders' Equity          
Net loss       (1,443) (1,443)
Proceeds upon issuance of common stock from exercise of stock options     3   3
Proceeds upon issuance of common stock from exercise of stock options (in shares)   562      
Issuance of common stock for Board fees and consulting services     53   53
Issuance of common stock for Board fees and consulting services (in shares)   2,221      
Stock-based compensation     993   993
Balance at end of period at Mar. 31, 2026   $ 18 $ 118,395 $ (104,246) $ 14,167
Balance at end of period (in shares) at Mar. 31, 2026 47 1,783,682